Thoughts on God and Stuff
I have been in Russia for a bit over a week now. I decided to try to take the “easy” route, and only wear my Omnipod. It seemed it would be easier to carry a few pods and a couple of bottles of regular insulin, instead of the many packages of Afrezza that inherently get questioned at international security. Compared […]
Read more
I received the OmniPod tubeless insulin pump system today, and these are my first thoughts. You can find information on the pump at this link. I will follow-up with more information in a later post. OmniPod Tubeless Insulin Pump System The OmniPod Tubeless Insulin Pump System is an insulin pump that delivers insulin to diabetics. Unlike other pumps, the OmniPod […]
Read more
I have used the Minimed 630G Insulin Pump System by Medtronic for the past 30 days. This review is my opinion of the pump, both positive and negative. I have used insulin pumps since I got my first Disetronic H-Tron V-100 in 1994. I got a Minimed 506 pump in 1998 and have been a fan of the Minimed/Medtronic pumps since. Until now. […]
Read more
This blog post is part of the Community Viewpoint series. It talks about how the diabetes healthcare community views the inhaled insulin Afrezza. This is the product Mannkind Corporation calls “Outsulin.” The View of “Outsulin” Healthcare providers I know still have not heard of “Outsulin”. Outsulin is the latest marketing campaign from Mannkind Corporation. The campaign explains “Three hours after you take AFREZZA, your blood sugar returns […]
Read more
Community Viewpoints: A New Health Series This new set of articles is a series that focuses on the views of the health community. This health series focuses on topics like prescription drugs, medical devices, and health education. I usually Tweet on things like this, but 140 characters does not let me give complete community viewpoints. As a result, I started this blog […]
Read more
I have many requests to update my Afrezza status. This article describes only my health status related to using Afrezza. Later, I will write another article to describe community views I collect. Afrezza Status After 8 Months of Use In March of 2016, my Hemoglobin A1C was above 8. My diabetes was “uncontrolled.” Since then, I am using Tresiba for my basal […]
Read more
Here I am, 31 days after leaving for Russia, back in the States for the 4th day. I have many questions, because my use of Afrezza and Tresiba have gone up considerably. Reduced Tresiba in Russia My questions come partly from my earlier post, where I noted that I had reduced my basal insulin usage considerably upon arriving in Russia. When […]
Read more
I had a hard time picking the subject of this post. It came down to Afrezza and Tresiba in Russia as they were an easy subject for me. Afrezza and Tresiba an Easy Subject Why are Afrezza and Tresiba as easy subject? It is because life has been simple while in Russia, using these two drugs. I have been able to live a fairly […]
Read more
In my last post, I talked about what Afrezza is, my Type 1 diabetes background, and what Afrezza has done for me in a very short time. My trip to using Afrezza was a rocky road, however. I had done plenty of research on inhaled insulin, other’s experience with Afrezza (and Tresiba, which I now use for my basal insulin, […]
Read more
What is Afrezza? In short, it is an inhaled insulin created by MannKind Corporation, based on Technosphere technology, and until recently, marketed and distributed by Sanofi. If you want the short story and some rumors surrounding the breakup of Sanofi and MannKind, The Motley Fool has some tidbits you can read. What I will say about Afrezza, is it has greatly […]
Read more